Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting

References

• Beier, R. and Gebert, A. (1998) “Kinetics of particle uptake in the dome of Peyer’s patches”, Am. J. Physiol. Gastrointest. Liver Physiol. 275, G130–G137.
   PubMed Web of Science ®Google Scholar
• Bocci, V. (1991) “Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?”, Clin. Pharmacokinet. 21, 411–417.
   Google Scholar
• Bowersock, T.L., HogenEsch, H., Suckow, M., Guimond, P., Martin, S.,
   Google Scholar
• Borie, D., Torregrosa, S., Park, H. and Park, K. (1999) “Oral vaccination of animals with antigens encapsulated in alginate microspheres”, Vaccine 17, 1804–1811.
   PubMed Web of Science ®Google Scholar
• Brayden, D.J. (2001) “Oral vaccination in man using antigens in particles: current status”, Eur. J. Pharm. Sci. 14, 183–189.
   Web of Science ®Google Scholar
• Brayden, D.J. and O’Mahony, D.J. (1998) “Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines”, Pharm. Sci. Technol. 1, 291–299.
   Web of Science ®Google Scholar
• Cywes, C., Stamenkovic, I. and Wessels, M.R. (2000) “CD44 as a receptor for colonization of the pharynx by group A Streptococcus”, J. Clin. Investig. 106, 995–1002.
   Google Scholar
• Eldridge, J.H., Meulbroek, T.A., Staas, J.K., Tice, T.R. and Gilley, R.M. (1989) “Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral admini- stration and induce a disseminated mucosal immune response”, Adv. Exp. Med. Biol. 251, 191–202.
   Google Scholar
• Erbacher, P., Remy, J.S. and Behr, J.P. (1999) “Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway”, Gene Ther. 6, 138–145.
   PubMed Web of Science ®Google Scholar
• Florence, A.T. (1997) “The oral absorption of micro- and nano-parti- culates: neither exceptional nor unusual”, Pharm. Res. 14, 259–266.
   Google Scholar
• Florence, A.T. and Hussain, N. (2001) “Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas”, Adv. Drug Delivery Rev. 50, S69–S89.
   PubMed Web of Science ®Google Scholar
• Hanes, J., Cleland, J.L. and Langer, R. (1997) “New advances in microsphere-based single-dose vaccines”, Adv. Drug Delivery Rev. 28, 97–119.
   PubMed Web of Science ®Google Scholar
• Hillery, A.M., Jani, P.U. and Florence, A.T. (1994) “Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles”, J. Drug Target. 2, 151–156.
   PubMed Web of Science ®Google Scholar
• Hirao, E., Saito, T. and Kobayashi, M. (1993) “Selective delivery of pepleomycin to esophageal lymph nodes by activated carbon particles”, Anticancer Res. 13, 991–994.
   PubMed Web of Science ®Google Scholar
• Hussain, N. (2000) “Ligand-mediated tissue specific drug delivery”, Adv. Drug Delivery Rev. 43, 95–100.
   PubMed Web of Science ®Google Scholar
• Hussain, N. and Florence, A.T. (1998) “Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nano- particles”, Pharm. Res. 15, 153–156.
   Google Scholar
• Hussain, N., Jani, P. and Florence, A.T. (1997) “Enhanced oral uptake of tomato-lectin conjugated nanoparticles in the rat”, Pharm. Res. 14, 613–618.
   Google Scholar
• Hussain, N., Jaitely, V. and Florence, A.T. (2001) “Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics”, Adv. Drug Delivery Rev. 50, 107–142.
   PubMed Web of Science ®Google Scholar
• Jackson, G.S., Hosszu, L.L., Power, A., Hill, A.F., Kenney, J., Saibil, H., Craven, C.J., Waltho, J.P., Clarke, A.R. and Collinge, J. (1999) “Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations”, Science 283, 1935–1937.
   PubMed Web of Science ®Google Scholar
• Lavelle, E.C. (2001) “Targeted delivery of drugs to the gastrointestinal tract”, Crit. Rev. Ther. Drug Carrier Syst. 18, 341–386.
   PubMed Web of Science ®Google Scholar
• Lehr, C-M. (2000) “Lectin-mediated drug delivery: the second generation of bioadhesives”, J. Control. Release 65, 19–29.
   PubMed Web of Science ®Google Scholar
• Liu, H., Ruskon-Fourmestraux, A., Lavergne-Slove, A., Ye, H., Molina, T., Bouhnik, Y., Hamoudi, R.A., Diss, T.C., Dogan, A., Megraud, F., Rambaud, J.C., Du, M.Q. and Isaacson, P.G. (2001) “Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lym- phoma to Helicobacter pylori eradication therapy”, Lancet 357, 39–40.
   PubMed Web of Science ®Google Scholar
• Menard, D., Corriveau, L. and Beaulieu, J.F. (1999) “Insulin modulates cellular proliferation in developing human jejunum and colon”, Biol. Neonate 75, 143–151.
   PubMedGoogle Scholar
• Olivier, V., Meisen, I., Meckelein, B., Hirst, T.R., Peter-Katalinic, J., Schmidt, M.A. and Frey, A. (2003) “Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems”, Bioconjug. Chem. 14, 1203–1208.
   Google Scholar
• Opanasopit, P., Nishikawa, M. and Hashida, M. (2002) “Factors affecting drug and gene delivery: effects of interaction with blood components”, Crit. Rev. Ther. Drug Carrier Syst. 19, 191–233.
   PubMed Web of Science ®Google Scholar
• Pernet, P., Vittecoq, D., Kodjo, A., Randrianarisolo, M.H., et al. (1999) “Intestinal absorption and permeability in human immunodeficiency virus-infected patients”, Scand. J. Gastroenterol. 34, 29–34.
   Web of Science ®Google Scholar
• Perry, I., Iqbal, T. and Cooper, B. (2001) “Intestinal permeability in coeliac disease”, Lancet 358, 1729.
   PubMed Web of Science ®Google Scholar
• Saito, T., Hirao, E., Kuwahara, A., Shimoda, K. and Kobayashi, M. (1993) “High concentrations of pepleomycin delivered to lymph nodes in patients with esophageal cancer”, J. Exp. Clin. Cancer Res. 12, 261–264.
   Web of Science ®Google Scholar
• Sakuma, S., Sudo, R., Suzuki, N., Kikuchi, H., Akashi, M., Ishida, Y. and Hayashi, M. (2002) “Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine”, J. Control. Release 81, 281–290.
   PubMed Web of Science ®Google Scholar
• Seegers, J.F.M.L. (2002) “Lactobacillus as liver vaccine delivery vectors: progress and prospects”, Trends Biotechnol. 20, 508–515.
   PubMed Web of Science ®Google Scholar
• Shanahan, F. (2002) “Crohn’s disease”, Lancet 359, 62–69.
   PubMed Web of Science ®Google Scholar
• Singh, B., Hussain, N., Sathivel, T. and Florence, A.T. (2003) “Effect of physiological media on the stability of surface-adsorbed DNA- dendron-gold nanoparticles”, J. Pharm. Pharmacol. 55, 1635–1640. Steidler, L. (2003) “Genetically engineered probiotics”, Best Pract. Res. Clin. Gastroenterol. 17, 861–876.
   Google Scholar
• Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. and Remaut, E. (2000) “Treatment of murine colitis by Lactococcus lactis secreting interleukin-10”, Science 289, 1352– 1355.
   PubMed Web of Science ®Google Scholar
• Thanos, C., Sandor, M., Yong, J., Jacob, J., Yip, K.P., Harper, J., Morrell, C., Scherer, J. and Mathiowitz, E. (1999) “Inter-species uptake of polymeric particles”, Mater. Res. Soc. Symp. Proc. 550, 65–70.
   Google Scholar
• Viret, J.F., Favre, D., Wegmuller, B., Herzog, C., Que, J.U., Cryz, S.J., Jr and Lang, A.B. (1999) “Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria”, Infect. Immun. 67, 3680–3685.
   Google Scholar
• Wattenbarger, M.R., Graves, D.J. and Lauffenburger, D.A. (1990) “Specific adhesion of glycophorin liposomes to a lectin surface in shear flow”, Biophys. J. 57, 765–777.
   PubMed Web of Science ®Google Scholar
• Young, G.M., Badger, J.L. and Miller, V.L. (2000) “Motility is required to initiate host cell invasion by Yersinia enterocolitica”, Infect. Immun. 68, 4323-
   Google Scholar